Variation in Vaccine Response in Normal Populations
- 1 June 2004
- journal article
- review article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 5 (4) , 417-427
- https://doi.org/10.1517/14622416.5.4.417
Abstract
Genetic polymorphisms of the human leukocyte antigen (HLA) system significantly influence the variation in immune responses to viral vaccines. Considerable data on the genetic determinants of immune responses to the measles vaccine support the importance of HLA genes in determining the variation in vaccine response. HLA class I and class II, TAP, and HLA-DM allele associations with measles-specific antibody levels following measles vaccination have revealed, in part, the immunologic basis for mechanisms of measles immunity variation. Associations between HLA genotype and immune responses have also been reported for other vaccines and infectious diseases, such as hepatitis B and C, human papillomaviruses, and influenza. Vaccine pharmacogenomics may provide important insights for the design and development of new peptide-based vaccines against measles and other pathogens.Keywords
This publication has 100 references indexed in Scilit:
- Identification and Characterization of Novel, Naturally Processed Measles Virus Class II HLA-DRB1 PeptidesJournal of Virology, 2004
- Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccinationVaccine, 2003
- Associations between Human Leukocyte Antigens and Nonresponsiveness to Influenza VaccineThe Journal of Infectious Diseases, 2002
- Immune Responses to Measles and Mumps Vaccination of Infants at 6, 9, and 12 MonthsThe Journal of Infectious Diseases, 2001
- Twin studies of immunogenicity — determining the genetic contribution to vaccine failureVaccine, 2001
- Non trivial overlap distributions at zero temperatureZeitschrift für Physik B Condensed Matter, 2000
- DR human leukocyte antigens and disease severity in chronic hepatitis CJournal of Hepatology, 1996
- The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancerNature Medicine, 1995
- Genetic Prediction of Nonresponse to Hepatitis B VaccineNew England Journal of Medicine, 1989
- Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry?Immunology Today, 1989